"Hyperaldosteronism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
| Descriptor ID |
D006929
|
| MeSH Number(s) |
C19.053.800.604
|
| Concept/Terms |
Conn Syndrome- Conn Syndrome
- Syndrome, Conn
- Primary Hyperaldosteronism
- Hyperaldosteronism, Primary
- Conn's Syndrome
- Conns Syndrome
- Syndrome, Conn's
|
Below are MeSH descriptors whose meaning is more general than "Hyperaldosteronism".
Below are MeSH descriptors whose meaning is more specific than "Hyperaldosteronism".
This graph shows the total number of publications written about "Hyperaldosteronism" by people in this website by year, and whether "Hyperaldosteronism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperaldosteronism" by people in Profiles.
-
Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study. J Hypertens. 2019 05; 37(5):1083-1095.
-
Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives. Surgery. 2019 01; 165(1):221-227.
-
Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension. J Clin Endocrinol Metab. 2015 Aug; 100(8):2857-64.
-
Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism. Hypertension. 2015 Apr; 65(4):841-8.
-
Primary aldosteronism in hypertensive patients: clinical implications and target therapy. Eur J Clin Invest. 2014 Aug; 44(8):697-706.
-
Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension. J Clin Endocrinol Metab. 2013 Apr; 98(4):1409-16.
-
Response to the article: "primary aldosteronism: are we missing the wood for the trees?". Horm Metab Res. 2012 Nov; 44(12):927-8; author reply 929-30.
-
Timing and special concerns regarding endocrine surgery during pregnancy. Endocrinol Metab Clin North Am. 2003 Jun; 32(2):337-54.
-
Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clin Chem. 2002 Nov; 48(11):1919-23.
-
Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Am Surg. 2002 Mar; 68(3):253-6; discussion 256-7.